S. Métivier

发表论文 20 篇 · 总被引 60 次 · h-index 5

代表论文

Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis. (2025 · Journal of Hepatology · 被引 36)
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis. (2026 · Journal of Hepatology · 被引 11)
Bulevirtide monotherapy prevents liver decompensation and reduces mortality in patients with HDV-related cirrhosis: a case control study with propensity score weighted analysis (2024 · Digestive and Liver Disease · 被引 7)
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosis. (2025 · Journal of Hepatology · 被引 6)
OS-034 Safety and efficacy of REP 2139-Mg in hepatitis D patients with advanced liver disease: an international compassionate use program (2024 · Journal of Hepatology · 被引 5)
WED-291 Long risk of decompensation and HCC in patients with HDV- related compensated cirrhosis treated with Bulevirtide monotherapy for up to 144 weeks: the retrospective multicenter european study (Save-D) (2025 · Journal of Hepatology · 被引 4)